← Open Payments lookup

ESFANDIAR MAFI: Open Payments

NPI 1780656447 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$870 in 43 payments from 16 companies in 2025. Trend: 2023 $384 · 2024 $988 · 2025 $870

Food & beverage: $870
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.7$139
Exact Sciences Corporation7$115
Regeneron Healthcare Solutions, Inc.4$100
Abbott Laboratories3$69
PFIZER INC.3$66
Madrigal Pharmaceuticals2$64
Novo Nordisk Inc3$54
Corcept Therapeutics3$50
MOTIVA USA, LLC1$36
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$34

Products named: ENTYVIO, DUPIXENT, The Cologuard Plus Collection Kit, FREESTYLE LIBRE 3, REZDIFFRA, Korlym, Ozempic, Motiva Implant Matrix.

Industry payments across NY — which companies pay providers there.